AccurayARAY -1.10%40 Gross Margin % is 24.13% as of Mar. 2026, which is 37% below its 10-year median of 38.03. GuruFocus rates ARAY with a GF Score™ of 40/100 and a GF Value™ of $1.34 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Accuray ranks worse than 84.72% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Accuray's Gross Profit for the
three
months ended in Mar. 2026 was $25.3 Mil. Accuray's Revenue for the
three
months ended in Mar. 2026 was $104.8 Mil. Therefore, Accuray's Gross Margin % for the quarter that ended in Mar. 2026 was 24.13%.
Warning Sign:
Accuray Inc gross margin has been in long-term decline. The average rate of decline per year is -4.9%.
The historical rank and industry rank for Accuray's Gross Margin % or its related term are showing as below:
ARAY'
s Gross Margin % Range Over the Past 10 Years
Min: 26.81 Med: 38.03 Max: 40.25
Current: 26.81
During the past 13 years, the highestGross Margin % of Accuray was 40.25%. The lowest was 26.81%. And the median was 38.03%.
ARAY's Gross Margin % is ranked worse than 84.72% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs ARAY: 26.81
Accuray had a gross margin of 24.13% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Accuray was -4.90% per year.
Accuray (NAS:ARAY) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Accuray had a gross margin of 24.13% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Accuray Gross Margin % Related Terms
Accuray Gross Margin % Historical Data
* Premium members only.
The historical data trend for Accuray's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ARAY vs PAVM, BDMD, TELA: Gross Margin % Comparison
For the Medical Devices subindustry, Accuray's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accuray Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Accuray's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Accuray's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Accuray (ARAY) has a Gross Margin % of 24.13% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Accuray and its competitors. This is 37% below median its historical median of 38.03. Over the past decade, Accuray's Gross Margin % has ranged from 26.81 to 40.25. According to the industry distribution chart, Accuray ranks #682 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 84.7%.
Is Accuray's Gross Margin % too high?
Accuray's current Gross Margin % of 24.13% is 37% below median its 10-year median of 38.03. Over the past 10 years, this metric has ranged from a low of 26.81 to a high of 40.25. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Accuray's value of 24.13% is 53.7% below this industry median. Based on the distribution chart, Accuray ranks #682 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Accuray has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accuray's Gross Margin % compare to PAVM and BDMD?
According to the Medical Devices & Instruments industry distribution chart, Accuray ranks #682 out of 805 companies for Gross Margin %. This places Accuray in the lower half of its industry. The industry median Gross Margin % is 52.07. Accuray's value of 24.13% is 53.7% below this benchmark. Historically, Accuray's own Gross Margin % has ranged from 26.81 to 40.25 over the past decade. While the company's 10-year median is 38.03 vs. the industry median of 52.07, Accuray has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accuray's current Gross Margin % of 24.13% is 53.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Accuray and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accuray's current Gross Margin % is 24.13%, which is 37% below median its own 10-year median of 38.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accuray stock overvalued right now?
Based on GuruFocus' analysis, Accuray (ARAY) is currently considered Possible Value Trap. The stock's GF Value™ is $1.34, compared to a current price of $0.31 — trading 76.6% below its estimated fair value. The current Gross Margin % is 24.13%, which is 37% below median its 10-year median of 38.03 and 53.7% below the Medical Devices & Instruments industry median of 52.07. Accuray's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Accuray (ARAY), the current Gross Margin % is 24.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accuray (ARAY) Overvalued in 2026?
Based on GuruFocus' analysis, Accuray stock appears to be undervalued.
The current stock price of $0.31 is trading 76.6% below its estimated GF Value™ of $1.34.
GuruFocus considers Accuray to be Possible Value Trap.
Key valuation signals for ARAY:
Gross Margin %: 24.13% (37% below median its 10-year median of 38.03)
GF Value™: $1.34 vs. price of $0.31 (76.6% below fair value)
Industry Position: 53.7% below the Medical Devices & Instruments median (#682 of 805)
No single metric tells the full story. See the ARAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
40GF Score
Get the complete analysis for ARAY
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ARAY has been successfully added to your 
